Get the Stockscreener App
1.03
3.00%
0.03
Clearmind Medicine Inc stock is traded at $1.03, with a volume of 55,047.
It is up +3.00% in the last 24 hours and down -8.85% over the past month.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.
See More
Previous Close:
$1.00
Open:
$0.98
24h Volume:
55,047
Relative Volume:
0.07
Market Cap:
$4.39M
Revenue:
-
Net Income/Loss:
$-6.78M
P/E Ratio:
-0.0241
EPS:
-42.6996
Net Cash Flow:
$-4.67M
1W Performance:
+0.00%
1M Performance:
-8.85%
6M Performance:
-20.16%
1Y Performance:
-25.36%
1-Day Range:
$0.9729
$1.03
1-Week Range:
$0.9563
$1.05
52-Week Range:
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
1.03 | 5.49M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc Stock (CMND) Latest News
Clearmind Medicine Inc. Sees Relief Buying After Extended Drop2025 Breakouts & Breakdowns & Expert Approved Momentum Trade Ideas - mustnews.co.kr
What indicators show strength in Clearmind Medicine Inc.2025 Top Decliners & Free Risk Controlled Daily Trade Plans - Newser
Clearmind Medicine Inc. stock retracement – recovery analysisPortfolio Performance Report & High Accuracy Buy Signal Tips - Newser
Clearmind Medicine Inc. stock chart pattern explained2025 AllTime Highs & Smart Allocation Stock Tips - Newser
Will Clearmind Medicine Inc. benefit from macro trendsJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - Newser
Is Clearmind Medicine Inc. trending in predictive chart modelsMarket Weekly Review & Weekly Chart Analysis and Trade Guides - Newser
Can a trend reversal in Clearmind Medicine Inc. lead to recovery2025 Historical Comparison & Growth Oriented Trade Recommendations - Newser
Using Ichimoku Cloud for Clearmind Medicine Inc. technicalsStock Surge & Community Consensus Stock Picks - Newser
Detecting price anomalies in Clearmind Medicine Inc. with AIEarnings Overview Report & Weekly High Potential Stock Alerts - Newser
Can volume confirm reversal in Clearmind Medicine Inc.2025 Buyback Activity & Verified Short-Term Trading Plans - Newser
Risk vs reward if holding onto Clearmind Medicine Inc.Quarterly Investment Review & Community Trade Idea Sharing - Newser
Clearmind Medicine Inc. Inches Above Key Support — Safe to Hold - Newser
Analyzing net buyer seller activity in Clearmind Medicine Inc.Weekly Profit Recap & Free Safe Entry Trade Signal Reports - Newser
Clearmind Medicine Inc. stock trendline breakdownPortfolio Update Summary & Target Return Focused Stock Picks - Newser
Exit strategy if you’re trapped in Clearmind Medicine IncShort Setup & Accurate Technical Buy Alerts - Newser
Can Clearmind Medicine Inc. rally from current levelsJuly 2025 Closing Moves & Precise Buy Zone Tips - Newser
Will Clearmind Medicine Inc. benefit from green energy policiesPortfolio Growth Summary & Long Hold Capital Preservation Plans - sundaytimes.kr
Clearmind Medicine Inc. Stock Support and Resistance Levels You Should KnowJuly 2025 EndofMonth & Safe Capital Growth Tips - Newser
Is it time to cut losses on Clearmind Medicine Inc.July 2025 Rallies & Stepwise Entry/Exit Trade Alerts - Newser
Should you wait for a breakout in Clearmind Medicine Inc.July 2025 Technicals & Safe Entry Trade Reports - Newser
Institutional scanner results for Clearmind Medicine Inc.July 2025 Big Picture & AI Optimized Trade Strategies - Newser
Trend analysis for Clearmind Medicine Inc. this weekQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - Newser
How Clearmind Medicine Inc. stock performs during market volatilityJuly 2025 Summary & Free Safe Entry Trade Signal Reports - Newser
What makes Clearmind Medicine Inc. stock price move sharplySell Signal & Low Drawdown Trading Techniques - Newser
Will Volume Confirm Reversal in Clearmind Medicine Inc.2025 Technical Patterns & Verified Momentum Stock Alerts - classian.co.kr
Why Clearmind Medicine Inc. stock attracts strong analyst attentionBreakout Stocks with Huge Upside - thegnnews.com
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - MarketScreener
Short interest data insights for Clearmind Medicine Inc.Entry Confirmation Based on Volatility Analysis - Newser
Clearmind Medicine Inc Stock (CMND) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):